Event Details
Crinetics will host a conference call and webcast on Monday, September 11, 2023 at 8:00 a.m. ET to discuss the topline results from the Phase 3 PATHFNDR-1 study (NCT04837040) released on Sunday, September 10, 2023.
News & Events
Crinetics Topline Results from Paltusotine Phase 3 PATHFNDR-1 Study
Transforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
